PARIS--(BUSINESS WIRE)--Regulatory News:
Cellectis bioresearch, a subsidiary of Cellectis Group (Paris:ALCLS) (Alternext: ALCLS), the genome engineering specialist, announces the launch of VizuCELL cell lines, a tool for live cell imaging.
As live cell imaging has become a requisite analytical tool in most cell biology laboratories, Cellectis bioresearch has developed VizuCELL cell lines for biomedical research and cell biology.
VizuCELL cell lines offer an exceptional tool to study temporal and spatial dynamic processes in living cells in order to get critical insights into morphological changes and physiological events in real time.
VizuCELL are generated by utilizing our proprietary TALEN™ technology to tag endogenous genes with a fluorescent signal controlled by the endogenous promoter.